3 completed, 2 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Terminated 2 |
Follow alvimopan: new trials by email Literature Review of alvimopan trials Research Report on alvimopan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 RCT of Alvimopan vs. Placebo After CRS/HIPEC Alvimopan, Placebo - Ileus | Phase 2 | Terminated | University of California, San Diego | 84 | 2018-03-08 | 2021-08-18 |
| Entereg Laparoscopic Colon Resection Study Entereg, placebo - Laparoscopic Colonic Resection | Phase 2 | Completed | Hartford Hospital | 135 | 2010-11-01 | 2015-08-26 |
| Clinical Evaluation Of Alvimopan (SB767905) On Constipation And Related Symptoms Associated With Opioid alvimopan, Placebo, Alvimopan 0.5 mg/day - Cancer, Constipation | Phase 2 | Terminated | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 21 | 2006-04-01 | 2015-09-02 |
| Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects alvimopan, placebo - Cancer, Bowel Dysfunction | Phase 2 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 67 | 2004-09-01 | 2015-09-02 |
| Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication alvimopan, placebo - Constipation, Bowel Dysfunction | Phase 2 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 233 | 2003-10-01 | 2017-08-30 |
Constipation (3) · Intestinal Diseases (2) · Neoplasms (2) · Cancer Pain (1) · Ileus (1) · Opioid-Induced Constipation (1) · Peritoneal Neoplasms (1)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (3) · Hartford Hospital (1) · University of California, San Diego (1)
United States (4) · Canada (2) · Finland (2) · France (2) · Hong Kong (2) · New Zealand (2) · Pakistan (2) · Peru (2) · Poland (2) · Portugal (2) · Russia (2) · Spain (2) · United Kingdom (2) · Argentina (1) · Australia (1)
Joel M Baumgartner, MD, MAS (1)